Moderna, Inc. SEC filings MRNA
Moderna, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Mar 30, 2021. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 1, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 8, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 11, 2026 | May 6, 2026 |
| 8-K |
Current report
Results of operations
|
May 1, 2026 | May 1, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 5, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 11, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 24, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2025 | Nov 20, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 13, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 2, 2024 | Sep 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 23, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 9, 2024 | May 6, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 16, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2023 | May 3, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2023 | Jan 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 13, 2022 | Dec 13, 2022 |
| 8-K | Current report | Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 29, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 17, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 1, 2022 | May 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2022 | May 24, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
May 13, 2022 | May 10, 2022 |
| 8-K |
Current report
Officer or director change
|
May 11, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 3, 2022 | Apr 28, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 11, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 4, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Apr 29, 2021 | Apr 28, 2021 |
| 8-K |
Current report
Other events
|
Apr 28, 2021 | Apr 18, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 13, 2021 | Apr 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2021 | Apr 13, 2021 |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MRNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1682852
- Former names
- Moderna Therapeutics, Inc. (until Aug 24, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.